Determinants of time trade-off valuations for EQ-5D-5L health states: data from the Canadian EQ-5D-5L valuation study

Do chronic disease patients value generic health states differently from individuals with no chronic disease? A case of a multicultural Asian population

(2015) Mihir Gandhi et al.   Health and Quality of Life Outcomes

A Program of Methodological Research to Arrive at the New International EQ-5D-5L Valuation Protocol

(2014) Mark Oppe et al.   VALUE IN HEALTH

The Impact of Differences between Patient and General Population EQ-5D-3L Values on the Mean Tariff Scores of Different Patient Groups

(2014) Matthew H.R. Little et al.   VALUE IN HEALTH

Demographic Differences in Health Preferences in the United States

(2013) Benjamin M. Craig et al.   MEDICAL CARE

LEAD TIME TTO: LEADING TO BETTER HEALTH STATE VALUATIONS?

(2012) Arthur E. Attema et al.   HEALTH ECONOMICS

Are patients' judgments of health status really different from the general population?

(2011) Paul FM Krabbe et al.   Health and Quality of Life Outcomes

Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)

(2011) M. Herdman et al.   QUALITY OF LIFE RESEARCH

Thinking about it: thoughts about health and valuing QALYs

(2010) Paul Dolan   HEALTH ECONOMICS

A uniform time trade off method for states better and worse than dead: feasibility study of the ‘lead time’ approach

(2010) Nancy J. Devlin et al.   HEALTH ECONOMICS

Health State Valuations of Patients and the General Public Analytically Compared: A Meta-Analytical Comparison of Patient and Population Health State Utilities

(2009) Yvette Peeters et al.   VALUE IN HEALTH

Validation of Screening Questions for Limited Health Literacy in a Large VA Outpatient Population

(2008) Lisa D. Chew et al.   JOURNAL OF GENERAL INTERNAL MEDICINE